AG
NVO

AmeriFlex Group’s Novo Nordisk NVO Stock Holding History

AmeriFlex Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.5K Buy
967
+197
+26% +$9.33K 0.02% 496
2025
Q4 		$39.2K Sell
770
-816
-51% -$41.7K 0.02% 467
2025
Q3 		$88K Sell
1,586
-4,925
-76% -$288K 0.03% 344
2025
Q2 		$441K Buy
6,511
+525
+9% +$35.7K 0.23% 81
2025
Q1 		$416K Buy
5,986
+4,872
+437% +$402K 0.17% 122
2024
Q4 		$94.1K Buy
+1,114
New +$120K 0.04% 310

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

AmeriFlex Group's NVO Position: Q1 2026 in Review

AmeriFlex Group increased its Novo Nordisk (NVO) stake by 26% in Q1 2026, buying an estimated $9.33K and bringing the position to 967 shares worth $35.5K. The position accounts for 0.02% of the portfolio, ranked #496.

AmeriFlex Group first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $441K in Q2 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • AmeriFlex Group held 967 shares of Novo Nordisk worth $35.5K as of Q1 2026.
  • AmeriFlex Group bought 197 Novo Nordisk shares in Q1 2026, an estimated $9.33K.
  • Novo Nordisk made up 0.02% of AmeriFlex Group's portfolio in Q1 2026, its #496 holding.
  • AmeriFlex Group first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • AmeriFlex Group's Novo Nordisk position peaked at $441K in Q2 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.